These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23256724)

  • 21. Urinary retention with sertraline, haloperidol, and clonazepam combination.
    Benazzi F
    Can J Psychiatry; 1998 Dec; 43(10):1051-2. PubMed ID: 9868574
    [No Abstract]   [Full Text] [Related]  

  • 22. Carbon dioxide test as an additional clinical measure of treatment response in panic disorder.
    Valença AM; Nardi AE; Nascimento I; Zin WA; Versiani M
    Arq Neuropsiquiatr; 2002 Jun; 60(2-B):358-61. PubMed ID: 12131931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of clonazepam on quality of life and work productivity in panic disorder.
    Jacobs RJ; Davidson JR; Gupta S; Meyerhoff AS
    Am J Manag Care; 1997 Aug; 3(8):1187-96. PubMed ID: 10170301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treating comorbid ADHD, major depression, and panic.
    Schaller JL; Behar D
    J Neuropsychiatry Clin Neurosci; 1999; 11(4):516. PubMed ID: 10570768
    [No Abstract]   [Full Text] [Related]  

  • 25. Are there advances in pharmacotherapy for panic disorder? A systematic review of the past five years.
    Caldirola D; Alciati A; Riva A; Perna G
    Expert Opin Pharmacother; 2018 Aug; 19(12):1357-1368. PubMed ID: 30063164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactive case conference. First episode: depression and panic disorder.
    Dunner DL
    CNS Spectr; 2005 Sep; 10(9):696-7. PubMed ID: 16142209
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomized, naturalistic, parallel-group study for the long-term treatment of panic disorder with clonazepam or paroxetine.
    Nardi AE; Freire RC; Mochcovitch MD; Amrein R; Levitan MN; King AL; Valença AM; Veras AB; Paes F; Sardinha A; Nascimento I; de-Melo-Neto VL; Dias GP; E Silva AC; Soares-Filho GL; da Costa RT; Mezzasalma MA; de Carvalho MR; de Cerqueira AC; Hallak JE; Crippa JA; Versiani M
    J Clin Psychopharmacol; 2012 Feb; 32(1):120-6. PubMed ID: 22198456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study.
    Smith WT; Londborg PD; Glaudin V; Painter JR
    Am J Psychiatry; 1998 Oct; 155(10):1339-45. PubMed ID: 9766764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risks and benefits of medications for panic disorder: a comparison of SSRIs and benzodiazepines.
    Quagliato LA; Freire RC; Nardi AE
    Expert Opin Drug Saf; 2018 Mar; 17(3):315-324. PubMed ID: 29357714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addition of d-fenfluramine to benzodiazepines produces a marked improvement in refractory panic disorder--a case report.
    Hetem LA
    J Clin Psychopharmacol; 1996 Feb; 16(1):77-8. PubMed ID: 8834424
    [No Abstract]   [Full Text] [Related]  

  • 31. Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine.
    Nardi AE; Valença AM; Freire RC; Mochcovitch MD; Amrein R; Sardinha A; Levitan MN; Nascimento I; de-Melo-Neto VL; King AL; de O E Silva AC; Veras AB; Dias GP; Soares-Filho GL; da Costa RT; Mezzasalma MA; de Carvalho MR; de Cerqueira AC; Hallak JE; Crippa JA; Versiani M
    Braz J Med Biol Res; 2011 Apr; 44(4):366-73. PubMed ID: 21344132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical practice. Obsessive-compulsive disorder.
    Jenike MA
    N Engl J Med; 2004 Jan; 350(3):259-65. PubMed ID: 14724305
    [No Abstract]   [Full Text] [Related]  

  • 33. Carbon dioxide induced panic attacks and short term clonazepam treatment. Preliminary study.
    Nardi AE; Valença AM; Zin W; Nascimento I
    Arq Neuropsiquiatr; 1999 Jun; 57(2B):361-5. PubMed ID: 10450339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medication treatments for panic disorder and social phobia.
    Stein MB
    Depress Anxiety; 1998; 7(3):134-8. PubMed ID: 9656095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonazepam Treatment of Atrial Fibrillation in Panic Anxiety Patients: A Case Series.
    Kahn JP; Veras AB; Nardi AE; Curtis AB
    Psychosomatics; 2019; 60(5):528-532. PubMed ID: 30594312
    [No Abstract]   [Full Text] [Related]  

  • 36. Panic disorder patients at the time of air strikes.
    Starcevic V; Kolar D; Latas M; Bogojevic G; Kelin K
    Depress Anxiety; 2002; 16(4):152-6. PubMed ID: 12497646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder.
    Otto MW; Tuby KS; Gould RA; McLean RY; Pollack MH
    Am J Psychiatry; 2001 Dec; 158(12):1989-92. PubMed ID: 11729014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of a suffocation alarm system sensitive to clinically-effective treatments with the panicolytics clonazepam and fluoxetine.
    Schimitel FG; Müller CJ; Tufik S; Schenberg LC
    J Psychopharmacol; 2014 Dec; 28(12):1184-8. PubMed ID: 25277323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidepressants in panic disorder.
    Jefferson JW
    J Clin Psychiatry; 1997; 58 Suppl 2():20-4; discussion 24-5. PubMed ID: 9078990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis.
    Bakker A; van Balkom AJ; Spinhoven P
    Acta Psychiatr Scand; 2002 Sep; 106(3):163-7. PubMed ID: 12197851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.